Ortho-McNeil®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, is a healthcare company that draws on the rich patient care heritage of its 2 sister companies, Ortho-McNeil Pharmaceutical and Janssen Pharmaceutica. Both of these pharmaceutical companies are pioneers and leaders in various areas such as pain management, acid reflux disease and infectious diseases that remain central to Ortho-McNeil® today. Ortho-McNeil® is focused on providing the most innovative products, safe and effective treatments to advance patient care in Primary Care, hospitals and other care facilities. The recently launched PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, is dedicated to Primary Care – helping physicians meet their patients’ needs. We currently market products to treat pain, acid reflux disease, and infectious diseases. We recognize that there continues to be unmet patient needs and we’re committed to bringing to market scientific innovations in health care that will help healthcare professionals meet their patients’ needs. See our News Center for recent announcements regarding these efforts. In the United States, medications developed by Ortho-McNeil® or its partners include pain medication, as well as treatments for acid reflux disease and infectious diseases. Ortho-McNeil® continues to explore new opportunities to develop solutions for unmet healthcare needs through its network affiliations, including Johnson & Johnson Pharmaceutical Research & Development, L.L.C., as well as through relationships with academic and private sector research and development, and licensing and acquisition partners. We believe in the promise of better health care and the exceptional business results that partnering offers.